Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chengqing Wu

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Clinical Lymphoma, Myeloma & Leukemia|February 13, 2018
The Effect of Lenalidomide on Health-Related Quality of Life in Patients With Lower-Risk Non-del(5q) Myelodysplastic Syndromes: Results From the MDS-005 StudyValeria Santini, Antonio Almeida, Aristoteles Giagounidis, et al.
Contemporary Clinical Trials|September 22, 2015
A proposed statistical framework for the management of subgroup analyses for large clinical trialsXiaolong Luo, Peng Chen, Alan Chengqing Wu, et al.
Plos One|August 24, 2018
Comparison of the molecular characteristics of Mycoplasma pneumoniae from children across different regions of ChinaGuanhua Xue, Ming Li, Na Wang, et al.
Retina (Philadelphia, Pa.)|September 16, 2016
THE ASSOCIATION OF EPIRETINAL MEMBRANE WITH MACULAR HOLE FORMATION AFTER RHEGMATOGENOUS RETINAL DETACHMENT REPAIRRahul N Khurana, Charles C Wykoff, Alok S Bansal, et al.
Blood|August 24, 2021
Phase 1 study of oral azacitidine (CC-486) plus R-CHOP in previously untreated intermediate- to high-risk DLBCLPeter Martin, Nancy L Bartlett, Julio C Chavez, et al.
Brain Imaging and Behavior|September 27, 2024
Cortical microstructural alterations in different stages of Parkinson's diseaseXueqin Bai, Tao Guo, Xiaojun Guan, et al.
Endocrine-Related Cancer|December 9, 2010
A pilot genome-wide association study shows genomic variants enriched in the non-tumor cells of patients with well-differentiated neuroendocrine tumors of the ileumKyle M Walsh, Murim Choi, Kjell Oberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 22, 2019
AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent LymphomaJohn P Leonard, Marek Trneny, Koji Izutsu, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Clinical Lymphoma, Myeloma & Leukemia|February 13, 2018
The Effect of Lenalidomide on Health-Related Quality of Life in Patients With Lower-Risk Non-del(5q) Myelodysplastic Syndromes: Results From the MDS-005 StudyValeria Santini, Antonio Almeida, Aristoteles Giagounidis, et al.
Contemporary Clinical Trials|September 22, 2015
A proposed statistical framework for the management of subgroup analyses for large clinical trialsXiaolong Luo, Peng Chen, Alan Chengqing Wu, et al.
Plos One|August 24, 2018
Comparison of the molecular characteristics of Mycoplasma pneumoniae from children across different regions of ChinaGuanhua Xue, Ming Li, Na Wang, et al.
Retina (Philadelphia, Pa.)|September 16, 2016
THE ASSOCIATION OF EPIRETINAL MEMBRANE WITH MACULAR HOLE FORMATION AFTER RHEGMATOGENOUS RETINAL DETACHMENT REPAIRRahul N Khurana, Charles C Wykoff, Alok S Bansal, et al.
Blood|August 24, 2021
Phase 1 study of oral azacitidine (CC-486) plus R-CHOP in previously untreated intermediate- to high-risk DLBCLPeter Martin, Nancy L Bartlett, Julio C Chavez, et al.
Brain Imaging and Behavior|September 27, 2024
Cortical microstructural alterations in different stages of Parkinson's diseaseXueqin Bai, Tao Guo, Xiaojun Guan, et al.
Endocrine-Related Cancer|December 9, 2010
A pilot genome-wide association study shows genomic variants enriched in the non-tumor cells of patients with well-differentiated neuroendocrine tumors of the ileumKyle M Walsh, Murim Choi, Kjell Oberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 22, 2019
AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent LymphomaJohn P Leonard, Marek Trneny, Koji Izutsu, et al.
Pageof 4